Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Hidetaka Iwamoto"'
Autor:
Kenji Takahashi, Kazuya Koyama, Yu Ota, Hidetaka Iwamoto, Keisuke Yamakita, Satoshi Fujii, Yohei Kitano
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Although non-coding RNAs (ncRNAs) are involved in disease pathogenesis, their contributions to pancreatic ductal adenocarcinoma (PDAC) remain unclear. Recently, the interrelationship between two classes of ncRNA, long non-coding RNAs (lncRNAs), and m
Externí odkaz:
https://doaj.org/article/d484b448699b4077b4e166afedd1a030
Autor:
Shuichi Mitsunaga, Makoto Ueno, Masahiro Tsuda, Takamichi Kuwahara, Yukiko Takayama, Keiji Hanada, Hitoshi Yoshida, Kenji Takahashi, Kohei Nakata, Hideaki Iwama, Masafumi Ikeda, Satoshi Kobayashi, Ikuya Miki, Kazuo Hara, Ryota Higuchi, Akinori Shimizu, Tomohiro Nomoto, Hidetaka Iwamoto, Masafumi Nakamura, Etsuro Hatano, Hiroko Sudo, Satoko Takizawa, Atsushi Ochiai
Publikováno v:
Cancer Research. 83:6686-6686
Background: MicroRNA-665 (miR-665), an intracellular inhibitor of pancreatic cancer (PC) cells, might be a potential biomarker to detect pancreatobiliary cancer (PBca). We sought to determine the diagnostic ability of miR-665 as a serum biomarker for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::176ad7af85232a1f6f481ca0a290efc2
https://doi.org/10.1158/1538-7445.am2023-6686
https://doi.org/10.1158/1538-7445.am2023-6686
Autor:
Masakazu Haneda, Takayuki Kogure, Yuko Suzuki, Keisuke Yamakita, Hidetaka Iwamoto, Satoshi Fujii, Tushar Patel, Kenji Takahashi, Tsuguhito Ota, Yohei Kitano, Yu Ota
Publikováno v:
Cancer Science
The role of long noncoding RNAs (lncRNAs) in the epithelial‐mesenchymal transition (EMT) in pancreatic ductal adenocarcinoma (PDAC) is unclear. Some lncRNAs can be transferred by extracellular vesicles (EVs) and have potential as biomarkers. Here,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::67cfb3d013238cde4246ad2c5ea009e6
https://doi.org/10.1111/cas.14232
https://doi.org/10.1111/cas.14232
Autor:
Keisuke Yamakita, Yu Ota, Kazuya Koyama, Yohei Kitano, Satoshi Fujii, Hidetaka Iwamoto, Kenji Takahashi
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Frontiers in Oncology
Frontiers in Oncology
Although non-coding RNAs (ncRNAs) are involved in disease pathogenesis, their contributions to pancreatic ductal adenocarcinoma (PDAC) remain unclear. Recently, the interrelationship between two classes of ncRNA, long non-coding RNAs (lncRNAs), and m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b4159d114db362c20d88b373d216cc22
https://www.frontiersin.org/article/10.3389/fonc.2020.01013/full
https://www.frontiersin.org/article/10.3389/fonc.2020.01013/full
Autor:
Makoto Yoshida, Hirofumi Asakura, Shinichiro Takahashi, Yasuhiro Shimizu, Akira Fukutomi, Soichiro Morinaga, Kouji Yamamoto, Hirochika Toyama, Satoshi Hirano, Ippei Matsumoto, Teiichi Sugiura, Hidetaka Iwamoto, Sohei Satoi, Yuriko Takeda, Yasunaru Sakuma, Katsuhiko Uesaka
Publikováno v:
Journal of Clinical Oncology. 38:724-724
724 Background: Although neoadjuvant treatment (NAT) has been widely employed for resectable pancreatic ductal adenocarcinoma (PDAC), it is still unclear what kind of regimen is recommended. The aim of the study is to investigate which chemoradiother
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f9d1776c3269773f968b3c3e0deb210e
https://doi.org/10.1200/jco.2020.38.4_suppl.724
https://doi.org/10.1200/jco.2020.38.4_suppl.724
Autor:
Yohei Kitano, Hidetaka Iwamoto, Kenji Takahashi, Keisuke Yamakita, Yuko Suzuki, Tsuguhito Ota
Publikováno v:
Annals of Oncology. 30:ix141-ix142
Background Palonosetron (PALO) is a second-generation 5-hydroxytryptamine 3 receptor antagonist (5HT3RA) that has shown better efficacy than first-generation 5HT3RA (granisetron; GRA) in preventing chemotherapy-induced nausea and vomiting (CINV). PAL
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f6d9afeaf737302338ad32948cc325e2
https://doi.org/10.1093/annonc/mdz434.006
https://doi.org/10.1093/annonc/mdz434.006
Autor:
Hidetaka Iwamoto, Yohei Kitano, Keisuke Yamakita, Tsuguhito Ota, Yu Ota, Kenji Takahashi, Yuko Suzuki
Publikováno v:
Gastroenterology. 156:S-761
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e799a79f707c499c9753b537a8122aa1
https://doi.org/10.1016/s0016-5085(19)38843-2
https://doi.org/10.1016/s0016-5085(19)38843-2
Autor:
Keisuke Yamakita, Yuichi Makino, Hidetaka Iwamoto, Yohei Kitano, Tsuguhito Ota, Kenji Takahashi, Yu Ota
Publikováno v:
Gastroenterology. 154:S-94
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bb73f2d96341f7f52095e79dc2407dce
https://doi.org/10.1016/s0016-5085(18)30759-5
https://doi.org/10.1016/s0016-5085(18)30759-5
Autor:
Yohei Kitano, Keisuke Yamakita, Kaori Wada, Yuko Suzuki, Kenji Takahashi, Masakazu Haneda, Hidetaka Iwamoto
Publikováno v:
Pancreatology. 16:S176
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e7c46b4b47daa659b3a81c2ccaaaa8fe
https://doi.org/10.1016/j.pan.2016.06.635
https://doi.org/10.1016/j.pan.2016.06.635
Autor:
Yuko Suzuki, Yohei Kitano, Keisuke Yamakita, Kenji Takahashi, Masakazu Haneda, Hidetaka Iwamoto
Publikováno v:
Pancreatology. 16:S138
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::906a6be96f57c3a026e246aa19160249
https://doi.org/10.1016/j.pan.2016.06.497
https://doi.org/10.1016/j.pan.2016.06.497